Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 43
Filter
1.
Front Med (Lausanne) ; 11: 1380135, 2024.
Article in English | MEDLINE | ID: mdl-38638938

ABSTRACT

CPPD disease can affect patients' quality of life through its various clinical presentations. This mini-review discusses the evolution of CPPD from its discovery to current knowledge of its pathogenesis, genetic associations, diagnostics, and treatment options. Despite extensive research, the exact mechanisms of CPPD are not well understood, and there is a notable lack of knowledge about psychosocial impacts and patient experiences. This study aims to present a CPPD Disease Timeline identifying gaps in current knowledge and potential directions for future research. These findings contribute to a broader understanding of CPPD disease and emphasize the importance of continued research and innovation in this field.

2.
Rheumatol Int ; 43(4): 757-762, 2023 04.
Article in English | MEDLINE | ID: mdl-36635578

ABSTRACT

Fibromyalgia is characterised by widespread musculoskeletal pain, which may present with fatigue, depression, anxiety, sleep and cognitive disturbances. It is the second most prevalent rheumatic disease. An accurate diagnosis is challenging, since its symptoms may resemble diverse conditions such as carpal tunnel syndrome, Raynaud syndrome, Sjögren syndrome, amongst others. Neuropathic pain and autonomic dysfunction in fibromyalgia suggest the involvement of the nervous system. Ion channels, neurotransmitters and neuromodulators may play a role. Small fibre neuropathy (SFN) may also cause chronic widespread pain. SFN may occur in 50% of fibromyalgia patients, but its role in the disease is unknown. Despite several efforts to synthesise the evidence on the mechanisms for pain in fibromyalgia, there are few studies applying an integrative perspective of neurochemical, immunological, and neuroanatomical characteristics, and their relevance to the disease. This protocol aims to clarify the mechanisms of the central and peripheral nervous system associated with pain in fibromyalgia. We will retrieve published studies from Web of Science, MEDLINE, Scopus, EBSCOhost, Ovid and Google Scholar. All clinical studies or experimental models of fibromyalgia reporting imaging, neurophysiological, anatomical, structural, neurochemical, or immunological characteristics of the central or peripheral nervous systems associated with pain will be included. Exclusion criteria will eliminate studies evaluating pain without a standardised measure, studies written in languages different from Spanish or English that could not be appropriately translated, and studies whose full-text files could not be retrieved after all efforts made. A narrative synthesis will be performed.


Subject(s)
Chronic Pain , Fibromyalgia , Neuralgia , Rheumatic Diseases , Humans , Fibromyalgia/diagnosis , Chronic Pain/etiology
3.
Rheumatol Int ; 42(12): 2135-2140, 2022 12.
Article in English | MEDLINE | ID: mdl-36029320

ABSTRACT

Literature searches are important components of systematic reviews. They are not only informative of the retrieval process, but they also set the data to be analyzed and influence additional components of systematic reviews. Despite the available guidelines, several studies have shown that the quality of reporting in systematic reviews is deficient in several medical fields. Systematic reviews may not comply completely with those guidelines despite explicitly stating they do. This protocol intends to answer to what extent systematic reviews published in rheumatology journals have complied with the PRISMA's search strategy guidelines published in 2009. The objective of the study is to analyze the compliance with the PRISMA (2009) search strategy guidelines among systematic reviews published in leading rheumatology journals. Inclusion criteria for this umbrella review protocol are systematic reviews (with or without meta-analyses) that mention having followed the PRISMA statement (2009) in their methods section, and published in journals listed in the Rheumatology category of the Journal of Citations Report 2020. Exclusion criteria are articles published before 2009; retraction letters, notes, expressions of concern; systematic reviews using PRISMA 2020. Databases to be consulted are Web of Science, PubMed and Scopus, from inception to present. Data summaries will be presented in graphs, figures, tables and network maps. A narrative synthesis will be described. This protocol complies with guidelines such as PRISMA 2020, PRISMA-A, PRISMA-P, PRISMA-S, PRESS, and JBI Manual for evidence synthesis, as long as it is suitable for umbrella review protocols. Articles in any language will be considered.


Subject(s)
Periodicals as Topic , Rheumatology , Humans , Meta-Analysis as Topic , Research Report , Systematic Reviews as Topic
4.
Clin Rheumatol ; 41(7): 2241-2248, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35524149

ABSTRACT

"Paper mills" are unethical outsourcing agencies proficient in fabricating fraudulent manuscripts submitted to scholarly journals. In earlier years, the activity of such companies involved plagiarism, but their processes have gained complexity, involving the fabrication of images and fake results. The objective of this study is to examine the main features of retracted paper mills' articles registered in the Retraction Watch database, from inception to the present, analyzing the number of articles per year, their number of citations, and their authorship network. Eligibility criteria for inclusion: retracted articles in any language due to paper mill activity. Retraction letters, notes, and notices, for exclusion. We collected the associated citations and the journals' impact factors of the retracted papers from Web of Science (Clarivate) and performed a data network analysis using VOSviewer software. This scoping review complies with PRISMA 2020 statement and main extensions. After a thorough analysis of the data, we identified 325 retracted articles due to suspected operations published in 31 journals (with a mean impact factor of 3.1). These retractions have produced 3708 citations. Nearly all retracted papers have come from China. Journal's impact factor lower than 7, life sciences journals, cancer, and molecular biology topics were common among retracted studies. The rapid increase of retractions is highly challenging. Paper mills damage scientific research integrity, exacerbating fraud, plagiarism, fake images, and simulated results. Rheumatologists should be fully aware of this growing phenomenon.


Subject(s)
Biomedical Research , Scientific Misconduct , Authorship , Humans , Journal Impact Factor , Plagiarism , Publications
6.
Rheumatol Int ; 41(3): 519-528, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33427917

ABSTRACT

Peripheral neuropathy in patients with rheumatoid arthritis is associated with a maladaptive autoimmune response that may cause chronic pain and disability. Nerve conduction studies are the routine method performed when rheumatologists presume its presence. However, this approach is invasive, may not reveal subtle malfunctions in the early stages of the disease, and does not expose abnormalities in structures surrounding the nerves and muscles, limiting the possibility of a timely diagnosis. This work aims to present a narrative review of new technologies for the clinical assessment of peripheral neuropathy in Rheumatoid Arthritis. Through a bibliographic search carried out in five repositories, from 1990 to 2020, we identified three technologies that could detect peripheral nerve lesions and perform quantitative evaluations: (1) magnetic resonance neurography, (2) functional magnetic resonance imaging, and (3) high-resolution ultrasonography of peripheral nerves. We found these tools can overcome the main constraints imposed by the previous electrophysiologic methods, enabling early diagnosis.


Subject(s)
Arthritis, Rheumatoid/complications , Peripheral Nervous System Diseases/diagnostic imaging , Arthritis, Rheumatoid/diagnostic imaging , Arthritis, Rheumatoid/pathology , Humans , Magnetic Resonance Imaging/adverse effects , Magnetic Resonance Imaging/methods , Peripheral Nervous System Diseases/etiology , Peripheral Nervous System Diseases/pathology , Ultrasonography/adverse effects , Ultrasonography/methods
7.
Arch Cardiol Mex ; 91(Suplemento COVID): 001-011, 2021 12 20.
Article in English | MEDLINE | ID: mdl-33147597

ABSTRACT

BACKGROUND: The outbreak of COVID-19 has created a landslide of publications, from different sources and unequal impact. We considered that the first 3 months are crucial to understand how knowledge has been generated by performing a bibliometric analysis, including the citations to these articles to guide researchers in exploring this field, and to evaluate the relationship between confirmed COVID-19 cases and deaths with the number of papers per country. METHODS: Scientific publications were obtained from PubMed (January-March 2020) and their citations during the first 6 months retrieved from the Scopus database. An analysis of the number of papers by country, approach (type and category of publication), and impact was made. A multiple linear regression model was implemented to analyze the correlation between the number of publications and confirmed cases and deaths. RESULTS: A total of 2,530 publications were analyzed with 59,104 citations (23.4 citations/article), written by authors from 67 countries. China was the country with more publications (988, 39%) and more citations (36,416, 63%) followed by the United States with 423 articles (16.7%) and 7,458 citations (12.6%). The coauthorship network identified 10,756 authors. According to the multivariate analysis, both confirmed cases and deaths were significantly correlated with the number of publications per country (corrected by population size and gross domestic product). CONCLUSION: The correlation with the number of publications suggests that cases and deaths had some impact on the medical literature, reflecting how rapidly the scientific community has been on the frontline in the fight against COVID-19.


Subject(s)
Bibliometrics , Biomedical Research , COVID-19 , Biomedical Research/trends , China , Databases, Factual , Humans , Pandemics , Publications/statistics & numerical data , United States
8.
Curr Neuropharmacol ; 19(3): 334-348, 2021.
Article in English | MEDLINE | ID: mdl-32691714

ABSTRACT

BACKGROUND: For more than seven decades, ultrasound has been used as an imaging and diagnostic tool. Today, new technologies, such as focused ultrasound (FUS) neuromodulation, have revealed some innovative, potential applications. However, those applications have been barely studied to deal with neuropathic pain (NP), a cluster of chronic pain syndromes with a restricted response to conventional pharmaceuticals. OBJECTIVE: To analyze the therapeutic potential of low-intensity (LIFUS) and high-intensity (HIFUS) FUS for managing NP. METHODS: We performed a narrative review, including clinical and experimental ultrasound neuromodulation studies published in three main database repositories. DISCUSSION: Evidence shows that FUS may influence several mechanisms relevant for neuropathic pain management such as modulation of ion channels, glutamatergic neurotransmission, cerebral blood flow, inflammation and neurotoxicity, neuronal morphology and survival, nerve regeneration, and remyelination. Some experimental models have shown that LIFUS may reduce allodynia after peripheral nerve damage. At the same time, a few clinical studies support its beneficial effect on reducing pain in nerve compression syndromes. In turn, Thalamic HIFUS ablation can reduce NP from several etiologies with minor side-effects, but some neurological sequelae might be permanent. HIFUS is also useful in lowering non-neuropathic pain in several disorders. CONCLUSION: Although an emerging set of studies brings new evidence on the therapeutic potential of both LIFUS and HIFUS for managing NP with minor side-effects, we need more controlled clinical trials to conclude about its safety and efficacy.


Subject(s)
Neuralgia , Chronic Pain , Humans , Neuralgia/diagnostic imaging , Neuralgia/therapy , Peripheral Nerve Injuries , Ultrasonography
9.
EJIFCC ; 31(3): 197-207, 2020 Sep.
Article in English | MEDLINE | ID: mdl-33061875

ABSTRACT

INTRODUCTION: The Q223R polymorphism of the leptin receptor (LEPR) gene is one of the most common polymorphisms and it is believed to be associated with a damaged capacity of LEPR signaling and with high circulating leptin levels. METHODS: An observational, cross-sectional, analytical study was carried out in the Autonomous University of Ciudad Juarez, Mexico, where a sample of young adult participants (ranging from 18 to 30 years of age) was obtained. They were classified based on the results of body mass index: non-obese, and overweight/obese. The polymorphic variant was determined by Polymerase Chain Reaction (PCR) from the DNA sample and serum leptin levels were measured by Enzyme-Linked Immuno Sorbent Assay. RESULTS: A total of 159 participants were included (non-obese, n=103; overweight/obese, n=56). Leptin levels were 15.14±12.3 ng/mL in the non-obese group and 26.13±19.0 ng/mL in the overweight/obese group (p≤0.001). The allelic frequencies of the Q and R alleles of the LEPR gene in the studied subjects were as follows: non-obese, Q=0.56, R=0.44; overweight/obese, Q=0.62, R=0.38. The relative risk for the Q/Q genotype was 1.18 (Cl 0.53-2.34), for Q/R was 1.14 (Cl 0.59-2.18) and for R/R was 0.59 (Cl 0.23-1.50). CONCLUSIONS: This study shows that leptin levels are associated with overweight/obesity in Mexican young adults, but this is not related to the presence of the Q223R polymorphism in the LEPR gene, so the underlying mechanisms for a possible disturbance in leptin signaling in obese Mexican young adults await further studies.

10.
Neurosci Lett ; 734: 135095, 2020 08 24.
Article in English | MEDLINE | ID: mdl-32473195

ABSTRACT

Dehydroepiandrosterone (DHEA) modulates dopaminergic neurotransmission. It takes part in neurologic and psychiatric diseases involving monoamine neurotransmitters. Earlier results show that DHEA (120-min treatment) reduced striatal dopamine (DA) turnover in rats, suggesting a reduced DA release. Some investigations report that DHEA increases DA release but inhibits motor activity, which seems contradictory. This research examines the effect of DHEA on striatal DA release, its metabolism and motor activity. Male Wistar rats were implanted in the striatum with a cannula for in vivo microdialysis. DHEA was administered (120 mg/kg) and dialysates were collected for 280 min. A depolarizing stimulus was applied at 120 min. Samples were analyzed by HPLC-ED to determine the concentration of DA and its metabolites. The effect of DHEA on motor activity was also evaluated during 120 min. Extracellular DA concentration was greater in treated animals both before and after depolarization. In contrast, DHEA reduced the areas below the curves for DA metabolites and DA/metabolite ratios. DHEA also reduced motor activity, remarkably in the first 20 min after treatment. In summary, DHEA yielded a stimulatory effect on striatal DA release that was not reflected in neither DA metabolism nor motor activity. Thus, DHEA resembles the effect of typical antipsychotics, increasing DA release but reducing behavioral activation.


Subject(s)
Corpus Striatum/drug effects , Corpus Striatum/metabolism , Dehydroepiandrosterone/pharmacology , Dopamine/metabolism , Motor Activity/drug effects , Animals , Male , Rats , Rats, Wistar
11.
Clin Neurol Neurosurg ; 188: 105592, 2020 01.
Article in English | MEDLINE | ID: mdl-31760254

ABSTRACT

A 38-year-old male presented to the hospital with headache, fever, and meningeal signs. He had undergone a surgical review of a ventriculoperitoneal shunt system one month earlier. A head computed tomography scan showed hydrocephalus. His medical history included a human immunodeficiency virus infection identified four years before and resolved cryptococcal meningitis, which had necessitated the implantation of the shunt system. Ventricular cerebrospinal fluid (CSF) was obtained, which showed inflammation and, in culture, grew a Gram-negative bacillus identified as multidrug-resistant Klebsiella oxytoca. The shunt was removed and a ventricular drain was installed. Treatment with meropenem and amikacin was established without a response; the CSF white blood cell count continued to increase, with cultures remaining positive. The patient's clinical condition deteriorated to stupor. With informed consent, intraventricular (ITV) treatment with tigecycline was initiated at a dose of 5 mg every 24 h and, three days later, the CSF cultures were negativized. Tigecycline levels in the CSF were quantified by liquid chromatography with ultraviolet detection and showed peak concentrations achieved at two hours after the dose of between 178 and 310 µg/mL. After 11 days of treatment with ITV tigecycline and eight negative CSF cultures, a new CSF shunt was installed. During follow-up review 10 months later, the patient reported he was working. The dose of tigecycline used in this study produced levels 15 to 20 times the minimum inhibitory concentration of the bacteria for up to six hours with adequate tolerance.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Cerebral Ventriculitis/drug therapy , Drug Resistance, Multiple, Bacterial , Klebsiella Infections/drug therapy , Surgical Wound Infection/drug therapy , Tigecycline/therapeutic use , Ventriculoperitoneal Shunt , Adult , Anti-Bacterial Agents/cerebrospinal fluid , Anti-HIV Agents/therapeutic use , Cerebral Ventriculitis/complications , Cerebral Ventriculitis/diagnosis , Cerebral Ventriculitis/microbiology , Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/therapeutic use , HIV Infections/complications , HIV Infections/drug therapy , Humans , Injections, Intraventricular , Klebsiella Infections/complications , Klebsiella Infections/diagnosis , Klebsiella Infections/microbiology , Klebsiella oxytoca/isolation & purification , Klebsiella oxytoca/physiology , Male , Microbial Sensitivity Tests , Surgical Wound Infection/complications , Surgical Wound Infection/diagnosis , Surgical Wound Infection/microbiology , Tigecycline/cerebrospinal fluid
12.
Clin Rheumatol ; 38(6): 1785-1789, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31093788

ABSTRACT

Social media has become a key component of contemporary medicine, and the rheumatology subspecialty is not an exemption. We found that just six of the 40 key peer-reviewed rheumatology journals have found it sensible to incorporate the new appointment of a Social Media Editor-or a similar designation-into their Editorial Boards. We propose that the role of a social media editor is a trinomial: not only a technological work to promote digital engagement but also an activity of ethical guidance and a cultural challenge dealing with worldwide cultural and mindset diversity.


Subject(s)
Editorial Policies , Publishing/trends , Social Media/trends , Humans , Information Dissemination/methods , Periodicals as Topic , Rheumatology/trends
13.
Article in English | MEDLINE | ID: mdl-31108178

ABSTRACT

We have investigated the effect of the local activation of histamine H3 receptors (H3Rs) in the rat prefrontal cortex (PFCx) on the impairment of pre-pulse inhibition (PPI) of the startle response induced by the systemic administration of MK-801, antagonist at glutamate N-Methyl-d-Aspartate (NMDA) receptors, and the possible functional interaction between H3Rs and MK-801 on PFCx dopaminergic transmission. Infusion of the H3R agonist RAMH (19.8 ng/1 µl) into the PFCx reduced or prevented the inhibition by MK-801 (0.15 mg/kg, ip) of PPI evoked by different auditory stimulus intensities (5, 10 and 15 dB), and the RAMH effect was blocked by the H3R antagonist/inverse agonist ciproxifan (30.6 ng/1 µl). MK-801 inhibited [3H]-dopamine uptake (-45.4 ±â€¯2.1%) and release (-32.8 ±â€¯2.6%) in PFCx synaptosomes or slices, respectively, and molecular modeling indicated that MK-801 binds to and blocks the rat and human dopamine transporters. However, H3R activation had no effect on the inhibitory action of MK-801 on dopamine uptake and release. In PFCx slices, MK-801 and the activation of H3Rs or dopamine D1 receptors (D1Rs) stimulated ERK-1/2 and Akt phosphorylation. The co-activation of D1Rs and H3Rs prevented ERK-1/2 and Akt phosphorylation, and H3R activation or D1R blockade prevented the effect of MK-801. In ex vivo experiments, the intracortical infusion of the D1R agonist SKF-81297 (37 ng/1 µl) or the H3R agonist RAMH increased Akt phosphorylation, prevented by D1R/H3R co-activation. These results indicate that MK-801 enhances dopaminergic transmission in the PFCx, and that H3R activation counteracts the post-synaptic actions of dopamine.


Subject(s)
Dizocilpine Maleate/pharmacology , Prepulse Inhibition/drug effects , Proto-Oncogene Proteins c-akt/metabolism , Receptors, Histamine H3/metabolism , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Reflex, Startle/drug effects , Animals , Benzazepines/administration & dosage , Benzazepines/pharmacology , Dizocilpine Maleate/administration & dosage , Dopamine/metabolism , Dopamine Plasma Membrane Transport Proteins/metabolism , Excitatory Amino Acid Antagonists/pharmacology , Histamine Agonists/administration & dosage , Histamine Agonists/pharmacology , Imidazoles/administration & dosage , Imidazoles/pharmacology , Male , Microinjections , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Molecular Docking Simulation , Phosphorylation/drug effects , Prefrontal Cortex/drug effects , Prefrontal Cortex/metabolism , Rats , Receptors, N-Methyl-D-Aspartate/metabolism , Tritium/metabolism
14.
Arch Med Res ; 50(8): 477-483, 2019 11.
Article in English | MEDLINE | ID: mdl-32018069

ABSTRACT

BACKGROUND: Delirium has important etiological, prognostic, and therapeutic implications. The study of neurochemical markers in this condition is relevant to the understanding of its pathophysiology. The assessment of the dopamine system is particularly relevant, as dopamine antagonists are the most used drugs in delirium. AIM: To analyze neurotransmission markers in patients with delirium, focusing in the dopamine metabolite, homovanillic acid. METHODS: A case-control study was performed at the National Institute of Neurology and Neurosurgery, Mexico, including hospitalized patients in which lumbar puncture was obtained for diagnostic purposes. Cases were selected if they fulfilled DSM-5 criteria for delirium. Age-paired controls were patients in which delirium was ruled out, selected at the same clinical scenario, during the same period. Neurological and systemic diagnoses were registered. Delirium was assessed using the DRS-98-R instrument. The dopamine metabolite, homovanillic acid (HVA), was measured by means of high-performance liquid chromatography. Other neurotransmission markers were also measured (5-hydroxyindoleacetic acid, glutamate, aspartate, GABA, glycine, arginine, citrulline, nitrites, and nitrates). A logistic regression model was used to determine pathogenic factors associated with the presence of delirium. RESULTS: 68 neurological patients with delirium and 68 patients without delirium were included. Higher homovanillic acid levels in cerebrospinal fluid were significantly associated with delirium. This result was significant after a subanalysis in patients without exposure to antipsychotics. Male gender and autoimmune limbic encephalitis were also associated with the presence of delirium. CONCLUSIONS: In hospitalized neurological patients, dopaminergic hyperactivity and autoimmune limbic encephalitis are pathogenic factors associated with the presence of delirium.


Subject(s)
Delirium/pathology , Dopamine/metabolism , Homovanillic Acid/cerebrospinal fluid , Homovanillic Acid/metabolism , Synaptic Transmission/physiology , Adult , Autoimmune Diseases/pathology , Biomarkers/metabolism , Case-Control Studies , Delirium/diagnosis , Delirium/drug therapy , Dopamine Antagonists/therapeutic use , Female , Humans , Hydroxyindoleacetic Acid , Limbic Encephalitis/pathology , Male , Mexico
15.
Postgrad Med ; 130(8): 669-672, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30321085

ABSTRACT

Despite its beneficial effects for the cardiovascular system, taurine remains a controversial substance. Taurine increases cardiac muscle strength and prevents arrhythmias, but its benefits go beyond this. Determining taurine levels may become an issue of life or death. In aneurysmal subarachnoid hemorrhage, taurine may be a warning signal informing of the risk of death in a patient. High plasma taurine levels may identify those patients at a high risk for death or a vegetative state at discharge from the hospital; thus, taurine may be a vital marker for the prognosis of this disorder. This is even more relevant considering that the result occurred in patients with a good neurological grade at admission that would usually receive a good prognosis but, despite this, one out of four died or remained in a vegetative state. Maybe taurine is key to explain this apparent paradox.


Subject(s)
Subarachnoid Hemorrhage/physiopathology , Taurine/blood , Biomarkers , Brain Edema/etiology , Brain Edema/physiopathology , Humans , Prognosis , Subarachnoid Hemorrhage/blood , Subarachnoid Hemorrhage/complications , Vasospasm, Intracranial/etiology , Vasospasm, Intracranial/physiopathology
16.
Salud Publica Mex ; 59(4): 429-436, 2017.
Article in English | MEDLINE | ID: mdl-29211264

ABSTRACT

Some interpretations frequently argue that three Disability Models (DM) (Charity, Medical/Rehabilitation, and Social) correspond to historical periods in terms of chronological succession. These views permeate a priori within major official documents on the subject in Mexico. This paper intends to test whether this association is plausible by applying a timeline method. A document search was made with inclusion and exclusion criteria in databases to select representative studies with which to depict milestones in the timelines for each period. The following is demonstrated: 1) models should be considered as categories of analysis and not as historical periods, in that the prevalence of elements of the three models is present to date, and 2) the association between disability models and historical periods results in teleological interpretations of the history of disability in Mexico.


Subject(s)
Disabled Persons/rehabilitation , Models, Theoretical , Attitude to Health , Charities/history , Disability Evaluation , Disabled Persons/history , Disabled Persons/statistics & numerical data , History, 16th Century , History, 17th Century , History, 18th Century , History, 19th Century , History, 20th Century , History, 21st Century , Mexico/epidemiology , Social Security/history , Social Welfare/history
17.
Rev. int. androl. (Internet) ; 15(4): 160-164, oct.-dic. 2017. ilus
Article in Spanish | IBECS | ID: ibc-166862

ABSTRACT

La concentración de deshidroepiandrosterona (DHEA) se reduce durante el envejecimiento y se asocia con la pérdida de bienestar. Esto se debe a que la DHEA tiene efecto antidepresivo, mejora la cognición y protege contra la muerte neuronal. Puede sugerirse que restituir en la edad avanzada los niveles de la DHEA que se observan en la juventud podría controlar tanto la depresión como la neurodegeneración. Se ha estudiado el efecto de la DHEA sobre el metabolismo de monoaminas para analizar los mecanismos involucrados en la depresión y la neurodegeneración con énfasis en la enfermedad de Parkinson, que cursa con ambas alteraciones. Los resultados muestran que la DHEA modula 2 de los principales sistemas dopaminérgicos cerebrales. La DHEA inhibe a monoamino oxidasa, lo que representa una oportunidad para intervenir en esta enfermedad pues la inhibición de esta enzima tiene efecto antidepresivo y neuroprotector. Este artículo discute los alcances y limitaciones de dichos hallazgos (AU)


Dehydroepiandrosterone (DHEA) concentration is reduced during aging, and is associated with the deterioration of our physical and mental health. This occurs because DHEA has an antidepressant effect, improves cognition and prevents neuronal death. It may therefore be suggested that restoring DHEA levels during aging to those observed in youth might control both depression and neurodegeneration. Thus, the effect of DHEA on monoamine metabolism has been studied in the rat brain, to analyze the underlying mechanisms of depression and neurodegeneration with emphasis in Parkinson disease, since it includes both symptoms. Results show that DHEA modulates 2 of the main dopaminergic systems in the brain. DHEA inhibits both monoamine oxidase (MAO) isoforms (A and B), which represents a therapeutic opportunity for this disease since MAO A inhibition yields an antidepressant effect, while that of MAO B is neuroprotective. This paper discusses the goals and limitations of our findings(AU)


Subject(s)
Humans , Male , Monoamine Oxidase Inhibitors/adverse effects , Monoamine Oxidase Inhibitors/therapeutic use , Dehydroepiandrosterone/administration & dosage , Depression/complications , Parkinson Disease/complications , Neuroprotection , Aging , Aging/physiology , Dopamine Agents/therapeutic use , Affect , Neurotransmitter Uptake Inhibitors/therapeutic use
18.
Salud pública Méx ; 59(4): 429-436, Jul.-Aug. 2017. tab
Article in English | LILACS | ID: biblio-903773

ABSTRACT

Abstract: Some interpretations frequently argue that three Disability Models (DM) (Charity, Medical/Rehabilitation, and Social) correspond to historical periods in terms of chronological succession. These views permeate a priori within major official documents on the subject in Mexico. This paper intends to test whether this association is plausible by applying a timeline method. A document search was made with inclusion and exclusion criteria in databases to select representative studies with which to depict milestones in the timelines for each period. The following is demonstrated: 1) models should be considered as categories of analysis and not as historical periods, in that the prevalence of elements of the three models is present to date, and 2) the association between disability models and historical periods results in teleological interpretations of the history of disability in Mexico.


Resumen: Se argumenta que tres modelos de discapacidad (de prescindencia, médico/rehabilitador y social) se corresponden con periodos históricos en sucesión cronológica. Esta visión a priori ha permeado dentro de los principales documentos oficiales sobre el tema en México. El presente trabajo se propone probar si esta asociación es plausible, mediante la aplicación de una metodología de línea temporal. Se diseñó una estrategia de búsqueda con criterios de inclusión y exclusión en bases de datos para seleccionar estudios representativos, con los cuales se retomaron hitos a representar en la línea temporal por cada periodo. Se muestra que los modelos deben plantearse como categorías de análisis y no como periodos históricos, dado que: 1) existe prevalencia de elementos de los tres modelos en la coyuntura actual y 2) la asociación entre modelos y periodos da lugar a interpretaciones teleológicas de la historia de la discapacidad en México.


Subject(s)
History, 16th Century , History, 17th Century , History, 18th Century , History, 19th Century , History, 20th Century , History, 21st Century , Disabled Persons/rehabilitation , Models, Theoretical , Social Security/history , Social Welfare/history , Attitude to Health , Charities/history , Disabled Persons/history , Disabled Persons/statistics & numerical data , Disability Evaluation , Mexico/epidemiology
19.
Nutr Neurosci ; 20(7): 388-395, 2017 Sep.
Article in English | MEDLINE | ID: mdl-26928375

ABSTRACT

Essential fatty acids have an important effect on oxidative stress-related diseases. The Huntington's disease (HD) is a hereditary neurologic disorder in which oxidative stress caused by free radicals is an important damage mechanism. The HD experimental model induced by quinolinic acid (QUIN) has been widely used to evaluate therapeutic effects of antioxidant compounds. The aim of this study was to test whether the fatty acid content in olive- or fish-oil-rich diet prevents against QUIN-related oxidative damage in rats. Rats were fed during 20 days with an olive- or a fish-oil-rich diet (15% w/w). Posterior to diet period, rats were striatally microinjected with QUIN (240 nmol/µl) or saline solution. Then, we evaluated the neurological damage, oxidative status, and gamma isoform of the peroxisome proliferator-activated receptor (PPARγ) expression. Results showed that fatty acid-rich diet, mainly by fish oil, reduced circling behavior, prevented the fall in GABA levels, increased PPARγ expression, and prevented oxidative damage in striatal tissue. In addition none of the enriched diets exerted changes neither on triglycerides or cholesterol blood levels, nor or hepatic function. This study suggests that olive- and fish-oil-rich diets exert neuroprotective effects.


Subject(s)
Corpus Striatum/drug effects , Fatty Acids, Essential/pharmacology , Oxidative Stress/drug effects , Quinolinic Acid/toxicity , Animals , Body Weight , Cholesterol/blood , Corpus Striatum/metabolism , Disease Models, Animal , Fish Oils/pharmacology , Huntington Disease/drug therapy , Lipid Peroxidation/drug effects , Male , Neuroprotective Agents/pharmacology , Olive Oil/pharmacology , Rats , Rats, Wistar , Triglycerides/blood , gamma-Aminobutyric Acid/metabolism
20.
Cir Cir ; 85(6): 493-498, 2017.
Article in Spanish | MEDLINE | ID: mdl-27993353

ABSTRACT

BACKGROUND: Positioning during neurosurgical procedures is a challenge for surgical teams even if precautions are taken, the mechanisms underlying peripheral nerve injury (elongation, compression or ischaemia) are latent and it is important to know the frequency of occurrence in our environment. OBJECTIVE: To analyze the frequency of peripheral nerve injury secondary to surgical positioning. MATERIALS AND METHODS: Prospective study including 163 patients scheduled for neurosurgical procedures. Four groups: supine, lateral, ventral and park bench were analyzed by neurological exploration in order to detect injury and relate with risk factors already described. RESULTS: In this study 112 patients were included, two patients who were under park bench position experienced paresthesias in ulnar region of less than 24 hours' duration; statistically significant correlation with body weight greater than 85kg. CONCLUSION: The incidence of peripheral nerve injury is low, understanding the mechanisms that may originate it helps towards prevention and early detection of complications.


Subject(s)
Craniotomy , Intraoperative Complications/etiology , Paresthesia/etiology , Peripheral Nerve Injuries/etiology , Posture , Ulnar Nerve/injuries , Adolescent , Adult , Aged , Comorbidity , Humans , Intraoperative Care , Intraoperative Complications/epidemiology , Middle Aged , Neurologic Examination , Patient Positioning , Peripheral Nerve Injuries/epidemiology , Prospective Studies , Risk Factors , Substance-Related Disorders/epidemiology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...